When it comes to natural cancer-fighting compounds, apigenin is steadily gaining attention from researchers and health advocates alike. Found abundantly in parsley, celery, chamomile, and other plant foods, apigenin is a plant-derived flavonoid known for its anti-inflammatory, antioxidant, and anti-cancer properties. But recent studies suggest it may also target one of cancer’s key metabolic weaknesses—its reliance on glutamine.
What Is Apigenin?
Apigenin is a type of flavone, a subclass of flavonoids, found in a wide range of fruits, vegetables, and herbs. It has been shown to:
Induce cell cycle arrest in cancer cells
Promote apoptosis (programmed cell death)
Inhibit angiogenesis (the formation of new blood vessels that feed tumors)
Suppress inflammation and oxidative stress
Modulate gene expression and enzymatic activity in cancer cells
One lesser-known mechanism by which apigenin exerts its anti-cancer effects involves its interaction with glutamine metabolism—a critical energy and biosynthesis pathway exploited by many tumors.
How Glutamine Feeds Cancer
Glutamine is the most abundant amino acid in the body and plays several vital roles in healthy physiology. However, in the context of cancer, glutamine becomes a double-edged sword.
Tumors—especially aggressive ones—rely heavily on glutamine for:
Energy production via anaplerosis (replenishing TCA cycle intermediates)
Nucleotide and amino acid synthesis (for rapid cell division)
Redox balance via glutathione synthesis
Supporting cell signaling pathways that fuel tumor growth
This phenomenon is often referred to as “glutamine addiction”—a hallmark of many cancers including glioblastoma, pancreatic, breast, and colorectal cancers.
A 2013 study in the Journal of Clinical Investigation found that targeting glutamine metabolism impairs tumor growth in multiple models, suggesting that interfering with this pathway could be a promising therapeutic strategy (PMID: 23455710).
Apigenin’s Role in Modulating Glutamine Uptake
Emerging research has shown that apigenin may interfere with glutamine metabolism in several ways:
Downregulating glutamine transporters (e.g., ASCT2/SLC1A5) on cancer cells, reducing glutamine uptake
Inhibiting glutaminase (GLS), the enzyme that converts glutamine to glutamate, a key step in fueling cancer metabolism
Modulating signaling pathways (e.g., mTOR, c-Myc) that drive glutamine addiction in tumors
A 2019 study in Biomedicine & Pharmacotherapy noted that apigenin suppresses c-Myc activity—a transcription factor that regulates glutamine transporters and enzymes—thus potentially starving cancer cells of this critical nutrient (PMID: 30703532).
This means that apigenin may make tumor cells less efficient at using glutamine, potentially increasing the availability of this amino acid for healthy tissues while impairing tumor growth.
Best Dietary Sources of Apigenin
To naturally boost your apigenin intake, consider adding these foods to your anti-cancer diet:
Parsley – one of the richest sources
Chamomile tea – widely consumed for relaxation, but also apigenin-rich
Celery and celery leaves
Onions
Oranges and grapefruit
Artichokes
Oregano, thyme, and basil
Final Thoughts
Apigenin offers a promising natural avenue for supporting cancer prevention and possibly complementing treatment—particularly in cancers that depend heavily on glutamine metabolism. While human trials are still needed to fully understand its therapeutic potential, current evidence from cell and animal studies is compelling.
Integrating apigenin-rich foods into your daily diet not only supports overall health but may also be a strategic step in weakening cancer’s metabolic advantage. When paired with other anti-cancer strategies, apigenin could help shift the balance in favor of healing and resilience. You can also purchase apigenin in supplement form.
Healthy Wishes
Wally Bishop I.N.H.C., C.N.C., C.I.C.P.
Board Certified Holistic Health Practitioner
Board Certified Functional Nutrition Coach
Remember: This information is for educational purposes and should not replace professional medical advice. Always consult with your healthcare provider about your individual health needs and cancer prevention strategies.
The contents of this blog is not and should not be considered medical advice. This blog is for informational purposes only. Always consult with your doctor before making any dietary or lifestyle changes. Never quit taking prescription medications unless advised to do so by your doctor.
______________________________________________________________________________________________________________________________________________________________________________________________
APA Reference List
Dang, C. V. (2013). Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells? Cell Cycle, 9(19), 3884–3886. https://doi.org/10.4161/cc.9.19.13588
DeBerardinis, R. J., & Cheng, T. (2010). Q’s next: The diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene, 29(3), 313–324. https://doi.org/10.1038/onc.2009.358
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016). From Krebs to clinic: Glutamine metabolism to cancer therapy. Nature Reviews Cancer, 16(10), 619–634. https://doi.org/10.1038/nrc.2016.71
Son, Y. O., Wang, X., Hitron, J. A., Zhang, Z., Cheng, S., Budhraja, A., & Shi, X. (2012). Cadmium induces autophagy through ROS-dependent activation of the LKB1–AMPK signaling in skin epidermal cells. Toxicology and Applied Pharmacology, 264(2), 265–272. https://doi.org/10.1016/j.taap.2012.08.003
Shukla, S., & Gupta, S. (2010). Apigenin: A promising molecule for cancer prevention. Pharmaceutical Research, 27(6), 962–978. https://doi.org/10.1007/s11095-010-0089-7
Wang, W., Heideman, L., Chung, C. S., Pelling, J. C., Koehler, K. J., & Birt, D. F. (2000). Cell cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Molecular Carcinogenesis, 28(2), 102–110. https://doi.org/10.1002/(SICI)1098-2744(200006)28:2<102::AID-MC6>3.0.CO;2-L
Li, Y., Yao, J., Han, C., Yang, J., Chaudhry, M. T., Wang, S., Liu, H., & Yin, Y. (2016). Quercetin, inflammation and immunity. Nutrients, 8(3), 167. https://doi.org/10.3390/nu8030167
Liskova, A., Samec, M., Koklesova, L., Smejkal, K., Samuel, S. M., Zhai, K., … & Büsselberg, D. (2021). Flavonoids against the Warburg phenotype—Concepts of predictive, preventive and personalized medicine to cut the Gordian knot of cancer cell metabolism. Epma Journal, 12, 27–47. https://doi.org/10.1007/s13167-021-00230-z
Ceti̇n, E., & Keski̇n, S. (2022). Apigenin suppresses cancer stem cell properties and induces mitochondrial apoptosis via the c-Myc pathway in breast cancer cells. Biomedicine & Pharmacotherapy, 145, 112423. https://doi.org/10.1016/j.biopha.2021.112423
Wang, L., Tu, Y. C., Lian, T. W., Hung, J. T., Yen, J. H., & Wu, M. J. (2006). Distinctive antioxidant and antiinflammatory effects of flavonols. Journal of Agricultural and Food Chemistry, 54(26), 9798–9804. https://doi.org/10.1021/jf0620719
